Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

GSK's fluticasone plus umeclidinium combination safe in phase I trial

May 22, 2014

Viral-induced overexpression of ITGA7 presented as a therapeutic approach for DMD

May 22, 2014

Synthetic MTDL as a novel therapeutic for ischemic stroke

May 22, 2014

Phase II results presented for relamorelin in chronic constipation, diabetic gastroparesis

May 21, 2014

GSK-2339345 proves safe in phase I trials for chronic cough

May 21, 2014

Preclinical and early clinical data presented for prodrug of Debio-1452

May 21, 2014

Novel biomarkers for Cushing's syndrome, HDR syndrome and MEN1 identified

May 21, 2014

NCL-1 impairs prostate cancer growth in vivo

May 20, 2014

MK-2206/ridaforolimus combination active in advanced breast cancer

May 20, 2014

Takeda presents phase III results for TAK-438

May 20, 2014

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 9, 2026.
Hengrui discovers new Nav1.8 blockers
BioWorld Science
Researchers from Jiangsu Hengrui Pharmaceuticals Co. Ltd. and Shanghai Hengrui Pharmaceutical Co. Ltd. have patented new sodium channel protein type 10 subunit α...
Hematopoietic stem cell research points to leukemia’s early roots
BioWorld Science
Hematopoietic stem cell (HSC) research over the past century has shown that leukemia may be driven by an invisible hand of inflammation. The bone marrow and...
Infinimmune presents preclinical data on anti-IL-22 antibody for atopic dermatitis
BioWorld Science
Infinimmune Inc. has recently presented results at the annual American Academy of Dermatology conference regarding their anti-IL-22 antibody IFX-101 for the...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026